AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2021
Jan 29, 2021
34129_dirs_2021-01-29_9ed813e2-9920-49d2-a910-5df80da5383e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2021-01-28
Reporting Person: Karrels James (SVP, CFO and Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-28 | Common Stock | M | 1000 | $0.94 | Acquired | 153460 | Direct |
| 2021-01-28 | Common Stock | M | 5000 | $1.51 | Acquired | 158460 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-28 | Employee stock option (right to buy) | $0.94 | M | 1000 | Disposed | 2022-03-13 | Common Stock (1000.0) | Direct |
| 2021-01-28 | Employee stock option (right to buy) | $1.51 | M | 5000 | Disposed | 2023-01-05 | Common Stock (5000.0) | Direct |
Footnotes
F1: The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18